.webp&w=384&q=75){kind=logo}
Loading, please wait...
Loading, please wait...
A toxicologic investigation reveals an outbreak of severe acquired methemoglobinemia caused by dermal absorption of the gasoline additive N-methylaniline in fuel-contaminated seawater. Understand the clinical presentation, urgent methylene blue management, and surveillance for delayed hemolytic anemia.
Primary cutaneous ALCL with a TCR-gamma-delta phenotype and DUSP22-IRF4 rearrangement represents a rare diagnostic challenge. Identifying this indolent profile avoids misclassification as aggressive lymphoma and prevents unnecessary systemic cytotoxic chemotherapy in elderly patients.
Recent breakthroughs in cellular therapy and quadruplet regimens have transformed multiple myeloma treatment decisions. Clinicians now integrate cytogenetics, functional fitness, and measurable residual disease to individualize therapy across newly diagnosed, smoldering, and relapsed disease settings.
Explore systematic evidence on frontline therapies for Philadelphia chromosome-negative adult B-ALL. Learn how targeted immunotherapies like blinatumomab redefine survival outcomes and address chemotherapy limitations in newly diagnosed patients.
Recent proteomic research from CSIR-IGIB identifies serotransferrin downregulation as a promising circulating biomarker for coronary artery disease. Reduced levels correlate inversely with cardiac troponin I, shedding light on vascular inflammation, functional iron deficiency, and early subclinical atherosclerosis.
